Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psychotropic drugs].

F Müller-Spahn1

  • 1Psychiatrische Klinik der Universität Basel.

Therapeutische Umschau. Revue Therapeutique
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

The development of psychotropic drugs, starting with Chlorpromazine, has significantly improved psychiatric disorder treatment compared to placebo. While effective, current treatments focus on symptom management rather than specific causal therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topics in contemporary psychiatric practice: Consent and ethics.

International journal of psychiatry in clinical practice·2014
Same author

Current use of atypical antipsychotics.

European psychiatry : the journal of the Association of European Psychiatrists·2013
Same author

Mania associated with mirtazepine treatment and mixed depression.

Pharmacopsychiatry·2010
Same author

Psychodrug-induced and EDTA associated thrombocytopenia: important factors in the differential diagnosis of low platelet counts.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Progression of bilateral striopallidal calcinosis and parkinsonism in a case of Gorlin syndrome.

The Journal of neuropsychiatry and clinical neurosciences·2009
Same author

Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells.

Cellular and molecular neurobiology·2009
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Clinical Psychiatry

Context:

  • The advent of Chlorpromazine in the 1950s initiated the era of psychotropic medications.
  • Psychotropic drugs encompass diverse compound classes, including anxiolytics, hypnotics, antidepressants, and antipsychotics.
  • These medications are widely prescribed for managing psychiatric disorders.

Purpose:

  • To review the evolution and efficacy of psychotropic drugs in psychiatric care.
  • To highlight advancements in psychotropic medication development.
  • To discuss the current approach to psychotropic drug administration.

Summary:

  • Psychotropic drugs have proven more effective than placebo in treating psychiatric disorders.
  • Recent decades have seen new antidepressants and antipsychotics with improved side-effect profiles, expanding treatment options.

Related Experiment Videos

  • Current psychotropic drug administration is syndrome-related, lacking specific causal therapies.

    • Impact:

    • Psychotropic medications have dramatically improved the management and course of various psychiatric disorders.
    • The availability of newer agents with better side-effect profiles enhances patient outcomes and treatment adherence.
    • Despite advancements, the field still aims for more targeted, causal therapies for psychiatric conditions.